Utilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other Diseases
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Utilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other Diseases
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-07-22
DOI
10.3389/fimmu.2016.00278
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dimethyl fumarate attenuates experimental autoimmune neuritis through the nuclear factor erythroid-derived 2-related factor 2/hemoxygenase-1 pathway by altering the balance of M1/M2 macrophages
- (2016) Ranran Han et al. Journal of Neuroinflammation
- Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS
- (2015) Benedetta Parodi et al. ACTA NEUROPATHOLOGICA
- Gastro-protective and Anti-stress Efficacies of Monomethyl Fumarate and a Fumaria indica Extract in Chronically Stressed Rats
- (2015) Anshul Shakya et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Dimethyl fumarate attenuates cerebral edema formation by protecting the blood–brain barrier integrity
- (2015) Reiner Kunze et al. EXPERIMENTAL NEUROLOGY
- Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway
- (2015) Qin Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells
- (2015) Axel Haarmann et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Anti-CD40-induced inflammatory E-cadherin+ dendritic cells enhance T cell responses and antitumour immunity in murine Lewis lung carcinoma
- (2015) Yong Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
- (2015) Erin E Longbrake et al. Multiple Sclerosis Journal
- Dimethyl fumarate confers neuroprotection by casein kinase 2 phosphorylation of Nrf2 in murine intracerebral hemorrhage
- (2015) Loretta O. Iniaghe et al. NEUROBIOLOGY OF DISEASE
- Vitamin D3 and Monomethyl Fumarate Enhance Natural Killer Cell Lysis of Dendritic Cells and Ameliorate the Clinical Score in Mice Suffering from Experimental Autoimmune Encephalomyelitis
- (2015) Zaidoon Al-Jaderi et al. Toxins
- Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
- (2015) Erin E Longbrake et al. Multiple Sclerosis Journal
- Dimethyl fumarate protection against collagen II degradation
- (2014) Ye Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a
- (2014) Heidi Vego et al. Cellular & Molecular Immunology
- Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate’s protective effect in EAE
- (2014) Hui Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Cyclin-Dependent Kinase 9 Inhibition Protects Cartilage From the Catabolic Effects of Proinflammatory Cytokines
- (2014) Jasper H. N. Yik et al. Arthritis & Rheumatology
- Dimethyl Fumarate for Treatment of Multiple Sclerosis: Mechanism of Action, Effectiveness, and Side Effects
- (2013) Ralf A. Linker et al. Current Neurology and Neuroscience Reports
- Dimethyl fumarate (BG-12) for the treatment of multiple sclerosis
- (2013) Martin Stangel et al. Expert Review of Clinical Pharmacology
- Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters
- (2012) De-Hyung Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling
- (2012) Haiyan Peng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dimethylfumarate Attenuates Renal Fibrosis via NF-E2-Related Factor 2-Mediated Inhibition of Transforming Growth Factor-β/Smad Signaling
- (2012) Chang Joo Oh et al. PLoS One
- The Anti-Inflammatory Effects of Dimethyl Fumarate in Astrocytes Involve Glutathione and Haem Oxygenase-1
- (2011) Shao Xia Lin et al. ASN Neuro
- Fumaric acid and its esters: An emerging treatment for multiple sclerosis with antioxidative mechanism of action
- (2011) R. Gold et al. CLINICAL IMMUNOLOGY
- Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
- (2011) Kamran Ghoreschi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Dimethylfumarate Inhibits Angiogenesis In Vitro and In Vivo: A Possible Role for Its Antipsoriatic Effect?
- (2011) Melissa García-Caballero et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- E-Cadherin Marks a Subset of Inflammatory Dendritic Cells that Promote T Cell-Mediated Colitis
- (2010) Karima R.R. Siddiqui et al. IMMUNITY
- The role of drugs in the induction and/or exacerbation of psoriasis
- (2010) Kabbur Hanumanthappa Basavaraj et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Microglial activation and chronic neurodegeneration
- (2010) Melinda E. Lull et al. Neurotherapeutics
- Fumarase: A Mitochondrial Metabolic Enzyme and a Cytosolic/Nuclear Component of the DNA Damage Response
- (2010) Ohad Yogev et al. PLOS BIOLOGY
- The Double-Edged Sword of Autoimmunity: Lessons from Multiple Sclerosis
- (2010) Anne Lise K. Hestvik Toxins
- Fumaric Acid and its Esters: An Emerging Treatment for Multiple Sclerosis
- (2009) D. Moharregh-Khiabani et al. Current Neuropharmacology
- The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist
- (2008) Hua Tang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fumarates for the treatment of multiple sclerosis: potential mechanisms of action and clinical studies
- (2008) Ralf A Linker et al. Expert Review of Neurotherapeutics
- Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
- (2008) Ludwig Kappos et al. LANCET
- Molecular mechanisms of Nrf2-mediated antioxidant response
- (2008) Wenge Li et al. MOLECULAR CARCINOGENESIS
- The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis
- (2008) D A Frohlich et al. ONCOGENE
- Dimethylfumarate Reduces Leukocyte Rolling in Vivo through Modulation of Adhesion Molecule Expression
- (2007) Simone A. Rubant et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search